Apogee Therapeutics Inc (APGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Operating Expenses | 216,870 | 93,003 | 30,727 |
| Operating Income | -216,870 | -93,003 | -30,727 |
| Interest Expense | 0 | 0 | 9,150 |
| Other Income | 34,742 | 9,018 | 92 |
| Pre-tax Income | -182,128 | -83,985 | -39,785 |
| Income Tax | 18 | N/A | N/A |
| Net Income Continuous | -182,146 | -83,985 | -39,785 |
| Net Income | $-182,146 | $-83,985 | $-39,785 |
| EPS Basic Total Ops | -3.30 | -3.36 | -16.16 |
| EPS Basic Continuous Ops | -3.30 | -3.36 | -16.16 |
| EPS Diluted Total Ops | -3.30 | -3.36 | -16.16 |
| EPS Diluted Continuous Ops | -3.30 | -3.36 | -16.16 |
| EPS Diluted Before Non-Recurring Items | -3.30 | -3.36 | N/A |
| EBITDA(a) | $-228,922 | $-96,074 | $-30,727 |